Hamilton Thorne (CVE:HTL) Trading 4.3% Higher – Still a Buy?

Hamilton Thorne Ltd. (CVE:HTLGet Free Report) traded up 4.3% during mid-day trading on Monday . The stock traded as high as C$1.45 and last traded at C$1.45. 25,700 shares traded hands during trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Trading Up 4.3%

The company has a market cap of C$149.69 million, a price-to-earnings ratio of 58.94 and a beta of 0.54. The firm has a 50-day moving average price of C$1.45 and a 200 day moving average price of C$1.45. The company has a current ratio of 2.04, a quick ratio of 2.25 and a debt-to-equity ratio of 43.24.

About Hamilton Thorne

(Get Free Report)

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.

Featured Stories

Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.